Atypical Antipsychotics and a Src Kinase Inhibitor (PP1) Prevent Cortical Injury Produced by the Psychomimetic, Noncompetitive NMDA Receptor Antagonist MK-801-Reference-Cited by-同舟云学术

Atypical Antipsychotics and a Src Kinase Inhibitor (PP1) Prevent Cortical Injury Produced by the Psychomimetic, Noncompetitive NMDA Receptor Antagonist MK-801

Published:2005-08-17 Issue:7 Volume:31 Page:1420-1430
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Dickerson Jon,Sharp Frank R

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/1300878.pdf

Reference71 articles.

1. Abdul-Monim Z, Reynolds GP, Neill JC (2003). The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J Psychopharmacol 17: 57–65.

2. Akiyama C, Yuguchi T, Nishio M, Tomishima T, Fujinaka T, Taniguchi M et al (2004). Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats. J Neurotrauma 7: 923–931.

3. Auer RN (1994). Assessing structural changes in the brain to evaluate neurotoxicological effects of NMDA receptor antagonists. Psychopharmacol Bull 30: 585–591.

4. Auer RN (1996). Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats. Stroke 27: 743–746.

5. Auer RN, Coulter KC (1994). The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801. Acta Neuropathol (Berlin) 87: 1–7.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex difference alters the behavioral and cognitive performance in a rat model of schizophrenia induced by sub-chronic ketamine;Journal of Psychiatric Research;2024-10

2. Pharmacogenetic activation of parvalbumin interneurons in the prefrontal cortex rescues cognitive deficits induced by adolescent MK801 administration;Neuropsychopharmacology;2023-04-11

3. Differential expression of miR-148b, miR-129-2 and miR-296 in animal models of schizophrenia-Relevance to NMDA receptor hypofunction;Neuropharmacology;2022-06

4. Novel microRNAs targeting NMDA receptor subunits in animal models of schizophrenia;2021-10-05

5. Ketamine's schizophrenia-like effects are prevented by targeting PTP1B;Neurobiology of Disease;2021-07